On May 2, 2025, the board of directors of the Company appointed Wu-Kwan Kit, 43, as Chief Compliance Officer and Secretary of the Company effective immediately.
Departed
Joshua M. Levinson
Chief Compliance Officer and Secretary
Golub Capital Direct Lending Unlevered Corp
Effective
2025-05-02
Successor
Wu-Kwan Kit
Filed
May 8, 2025, 7:59 PM ET
On May 2, 2025, Joshua M. Levinson resigned from his position as Chief Compliance Officer and Secretary of Golub Capital Direct Lending Unlevered Corporation (the “Company”).
Departed
Joshua M. Levinson
Chief Compliance Officer and Secretary
Golub Capital BDC 4, Inc.
Effective
2025-05-02
Successor
Wu-Kwan Kit
Filed
May 8, 2025, 7:59 PM ET
On May 2, 2025, Joshua M. Levinson resigned from his position as Chief Compliance Officer and Secretary of Golub Capital BDC 4, Inc. (the “Company”).
Appointed
Wu-Kwan Kit
Chief Compliance Officer and Secretary
Golub Capital BDC 4, Inc.
Effective
2025-05-02
Filed
May 8, 2025, 7:59 PM ET
On May 2, 2025, the board of directors of the Company appointed Wu-Kwan Kit, 43, as Chief Compliance Officer and Secretary of the Company effective immediately.
Departed
Joshua M. Levinson
Chief Compliance Officer and Secretary
Golub Capital Private Credit Fund
Effective
2025-05-02
Successor
Wu-Kwan Kit
Filed
May 8, 2025, 7:59 PM ET
On May 2, 2025, Joshua M. Levinson resigned from his position as Chief Compliance Officer and Secretary of Golub Capital Private Credit Fund (the “Company”).
Appointed
Wu-Kwan Kit
Chief Compliance Officer and Secretary
Golub Capital Private Credit Fund
Effective
2025-05-02
Filed
May 8, 2025, 7:59 PM ET
On May 2, 2025, the board of trustees of the Company appointed Wu-Kwan Kit, 43, as Chief Compliance Officer and Secretary of the Company effective immediately.
Effective May 8, 2025, Jonathan Beigle, age 42, was appointed and elected a director by the unanimous vote of the members of the board of directors (“Board”) of the Company to fill the vacancy created by the resignation of Mr. Francis,
Todd J. Lepinski joining the Company as Senior Vice President, Sales and Marketing, effective as of June 2, 2025
Appointed
Paul Graves
Director
CRL ·
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Effective
2025-05-20
Filed
May 7, 2025, 7:59 PM ET
the Board has agreed to, as promptly as practical following the Annual Meeting of Stockholders scheduled for May 20, 2025, to elect the Cooperation Agreement Directors as members of the Board (to fill the vacancies described in the preceding paragraph), effective immediately following such election
Appointed
Abe Ceesay
Director
CRL ·
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Effective
2025-05-20
Filed
May 7, 2025, 7:59 PM ET
the Board has agreed to, as promptly as practical following the Annual Meeting of Stockholders scheduled for May 20, 2025, to elect the Cooperation Agreement Directors as members of the Board (to fill the vacancies described in the preceding paragraph), effective immediately following such election
Appointed
Steven Barg
Director
CRL ·
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Effective
2025-05-20
Filed
May 7, 2025, 7:59 PM ET
the Board has agreed to, as promptly as practical following the Annual Meeting of Stockholders scheduled for May 20, 2025, to elect the Cooperation Agreement Directors as members of the Board (to fill the vacancies described in the preceding paragraph), effective immediately following such election
Departed
George E. Massaro
Director
CRL ·
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Effective
2025-05-20
Filed
May 7, 2025, 7:59 PM ET
On May 6, 2025, Robert Bertolini, Deborah T. Kochevar, George E. Massaro and Richard F. Wallman each notified the Company of his or her decision to not stand for re-election to the Board at the 2025 Annual Meeting following the expiration of their respective terms prior to the 2025 Annual Meeting (resulting in four vacancies on the Board).
Departed
Deborah T. Kochevar
Director
CRL ·
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Effective
2025-05-20
Filed
May 7, 2025, 7:59 PM ET
On May 6, 2025, Robert Bertolini, Deborah T. Kochevar, George E. Massaro and Richard F. Wallman each notified the Company of his or her decision to not stand for re-election to the Board at the 2025 Annual Meeting following the expiration of their respective terms prior to the 2025 Annual Meeting (resulting in four vacancies on the Board).
Appointed
Mark Enyedy
Director
CRL ·
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Effective
2025-05-20
Filed
May 7, 2025, 7:59 PM ET
the Board has agreed to, as promptly as practical following the Annual Meeting of Stockholders scheduled for May 20, 2025, to elect the Cooperation Agreement Directors as members of the Board (to fill the vacancies described in the preceding paragraph), effective immediately following such election
Departed
Robert Bertolini
Director
CRL ·
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Effective
2025-05-20
Filed
May 7, 2025, 7:59 PM ET
On May 6, 2025, Robert Bertolini, Deborah T. Kochevar, George E. Massaro and Richard F. Wallman each notified the Company of his or her decision to not stand for re-election to the Board at the 2025 Annual Meeting following the expiration of their respective terms prior to the 2025 Annual Meeting (resulting in four vacancies on the Board).
Departed
Richard F. Wallman
Director
CRL ·
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Effective
2025-05-20
Filed
May 7, 2025, 7:59 PM ET
On May 6, 2025, Robert Bertolini, Deborah T. Kochevar, George E. Massaro and Richard F. Wallman each notified the Company of his or her decision to not stand for re-election to the Board at the 2025 Annual Meeting following the expiration of their respective terms prior to the 2025 Annual Meeting (resulting in four vacancies on the Board).
On May 7, 2025, the Company announced that Wendy P. Davidson has departed from her roles as the Company’s President and Chief Executive Officer and as a member of the Company’s Board of Directors (the “Board”), effective as of the end of the day on May 6, 2025 (the “Effective Date”).
the Board has appointed Alison E. Lewis, a member of the Board, to serve as Interim President and Chief Executive Officer, effective as of May 7, 2025.
the Company will present Mr. Wally Gruenes, a former National Managing Partner of Consumer and Industrial Products at Grant Thornton, for election to the Company’s Board of Directors at the annual shareholders meeting.
QuantumScape Corporation (the “Company”) announced today that Dr. Luca Fasoli is joining QuantumScape Battery, Inc., a wholly-owned subsidiary of the Company, as its Chief Operating Officer, effective May 7, 2025.
On May 7, 2025, Jones Lang LaSalle Incorporated (the “Company” or “JLL”) announced that Karen Brennan, currently the Company’s Chief Financial Officer and a member of JLL’s Global Executive Board (“GEB”), will assume a new role as the Company’s CEO of Leasing Advisory, effective July 1, 2025.
In connection with Ms. Brennan’s transition into her new role, the Company also announced the appointment of Kelly Howe, 53, as Chief Financial Officer of the Company, effective July 1, 2025.
On May 6, 2025, Chipotle Mexican Grill, Inc. (“Chipotle”) announced that it has hired Jason Kidd, age 50, as its Chief Operating Officer, effective May 19, 2025.
Chipotle also announced that Jack Hartung, Chipotle’s President and Chief Strategy Officer, notified the company on May 5, 2025 that he will step down from his executive officer position effective June 1, 2025.
On May 2, 2025, Jeremy Castle provided notice of his resignation as Chief Operating Officer of The Oncology Institute, Inc. (the “Company”), effective as of May 30, 2025.
Appointed
Clayton A. Carrell
President and Chief Operating Officer
CIVITAS RESOURCES, INC.
Effective
2025-05-07
Filed
May 7, 2025, 7:59 PM ET
On May 7, 2025, Civitas Resources, Inc. (the “Company”) appointed Clayton A. Carrell as the new President and Chief Operating Officer of the Company, effective immediately, reporting to the Company’s Chief Executive Officer.
Effective as of May 1, 2025, the following individuals were appointed to the board of directors of the Company: Ali Bouzarif, Kevin Gold and Sanford Litvack.
Effective as of May 1, 2025, the following individuals were appointed to the board of directors of the Company: Ali Bouzarif, Kevin Gold and Sanford Litvack.
Effective as of May 1, 2025, the following individuals were appointed to the board of directors of the Company: Ali Bouzarif, Kevin Gold and Sanford Litvack.
On such date, Michael P. Lyons, the President and CEO-Elect of the Company, became Chief Executive Officer and a director of the Company and ceased to be President of the Company.
On May 6, 2025 (the “Confirmation Date”), the U.S. Senate confirmed Frank J. Bisignano as the Commissioner of the Social Security Administration and Mr. Bisignano resigned as Chairman and Chief Executive Officer and a director of Fiserv, Inc. (the “Company”).
the notice of articles of New Lionsgate were amended to remove all directors of New Lionsgate and to name Gordon Crawford, Jon Feltheimer, Emily Fine, Michael T. Fries, John D. Harkey, Jr., Susan McCaw, Yvette Ostolaza, Dr. Mark H. Rachesky, Richard Rosenblatt and Harry E. Sloan as the directors of the New Lionsgate board of directors
the notice of articles of New Lionsgate were amended to remove all directors of New Lionsgate and to name Gordon Crawford, Jon Feltheimer, Emily Fine, Michael T. Fries, John D. Harkey, Jr., Susan McCaw, Yvette Ostolaza, Dr. Mark H. Rachesky, Richard Rosenblatt and Harry E. Sloan as the directors of the New Lionsgate board of directors
the notice of articles of New Lionsgate were amended to remove all directors of New Lionsgate and to name Gordon Crawford, Jon Feltheimer, Emily Fine, Michael T. Fries, John D. Harkey, Jr., Susan McCaw, Yvette Ostolaza, Dr. Mark H. Rachesky, Richard Rosenblatt and Harry E. Sloan as the directors of the New Lionsgate board of directors
the notice of articles of New Lionsgate were amended to remove all directors of New Lionsgate and to name Gordon Crawford, Jon Feltheimer, Emily Fine, Michael T. Fries, John D. Harkey, Jr., Susan McCaw, Yvette Ostolaza, Dr. Mark H. Rachesky, Richard Rosenblatt and Harry E. Sloan as the directors of the New Lionsgate board of directors
the following individuals, who had been previously serving in their respective positions shown below at Legacy LG Studios and Old Lionsgate, were removed from their respective positions of Old Lionsgate and Legacy LG Studios and appointed as executive officers of New Lionsgate (together, the “New Lionsgate Executive Officers”) as set forth in the table below: Jon Feltheimer Chief Executive Officer Michael Burns Vice Chair James W. Barge Chief Financial Officer Brian Goldsmith Chief Operating Officer Bruce Tobey Executive Vice President and General Counsel
the notice of articles of New Lionsgate were amended to remove all directors of New Lionsgate and to name Gordon Crawford, Jon Feltheimer, Emily Fine, Michael T. Fries, John D. Harkey, Jr., Susan McCaw, Yvette Ostolaza, Dr. Mark H. Rachesky, Richard Rosenblatt and Harry E. Sloan as the directors of the New Lionsgate board of directors
the notice of articles of New Lionsgate were amended to remove all directors of New Lionsgate and to name Gordon Crawford, Jon Feltheimer, Emily Fine, Michael T. Fries, John D. Harkey, Jr., Susan McCaw, Yvette Ostolaza, Dr. Mark H. Rachesky, Richard Rosenblatt and Harry E. Sloan as the directors of the New Lionsgate board of directors
the notice of articles of New Lionsgate were amended to remove all directors of New Lionsgate and to name Gordon Crawford, Jon Feltheimer, Emily Fine, Michael T. Fries, John D. Harkey, Jr., Susan McCaw, Yvette Ostolaza, Dr. Mark H. Rachesky, Richard Rosenblatt and Harry E. Sloan as the directors of the New Lionsgate board of directors
the notice of articles of New Lionsgate were amended to remove all directors of New Lionsgate and to name Gordon Crawford, Jon Feltheimer, Emily Fine, Michael T. Fries, John D. Harkey, Jr., Susan McCaw, Yvette Ostolaza, Dr. Mark H. Rachesky, Richard Rosenblatt and Harry E. Sloan as the directors of the New Lionsgate board of directors
the notice of articles of New Lionsgate were amended to remove all directors of New Lionsgate and to name Gordon Crawford, Jon Feltheimer, Emily Fine, Michael T. Fries, John D. Harkey, Jr., Susan McCaw, Yvette Ostolaza, Dr. Mark H. Rachesky, Richard Rosenblatt and Harry E. Sloan as the directors of the New Lionsgate board of directors
the following individuals, who had been previously serving in their respective positions shown below at Legacy LG Studios and Old Lionsgate, were removed from their respective positions of Old Lionsgate and Legacy LG Studios and appointed as executive officers of New Lionsgate (together, the “New Lionsgate Executive Officers”) as set forth in the table below: Jon Feltheimer Chief Executive Officer Michael Burns Vice Chair James W. Barge Chief Financial Officer Brian Goldsmith Chief Operating Officer Bruce Tobey Executive Vice President and General Counsel
the following individuals, who had been previously serving in their respective positions shown below at Legacy LG Studios and Old Lionsgate, were removed from their respective positions of Old Lionsgate and Legacy LG Studios and appointed as executive officers of New Lionsgate (together, the “New Lionsgate Executive Officers”) as set forth in the table below: Jon Feltheimer Chief Executive Officer Michael Burns Vice Chair James W. Barge Chief Financial Officer Brian Goldsmith Chief Operating Officer Bruce Tobey Executive Vice President and General Counsel
the notice of articles of New Lionsgate were amended to remove all directors of New Lionsgate and to name Gordon Crawford, Jon Feltheimer, Emily Fine, Michael T. Fries, John D. Harkey, Jr., Susan McCaw, Yvette Ostolaza, Dr. Mark H. Rachesky, Richard Rosenblatt and Harry E. Sloan as the directors of the New Lionsgate board of directors
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.